– UK, London – AstraZeneca PLC (LON: AZN | Nasdaq: AZN), today announced the appointment of Diana Layfield to its Board as a Non-Executive Director, effective from 1 November 2020.
“We are delighted that Diana is joining AstraZeneca’s Board. Her broad international business experience, which began in the pharmaceutical and biotech sector, encompasses leadership roles in international banking, global technology and a fintech start-up. Diana’s expertise in delivering innovation at scale coupled with her passion for life sciences will be of great value to AstraZeneca as we continue to grow and invest for the future.” said Board Chairman, Leif Johansson.
About Diana Layfield
Diana Layfield is President, EMEA Partnerships at Google, driving technology transformation and solutions across all Google product areas for major partners in the region. She is also VP, ‘Next Billion Users’ & Product Management, leading the development of products and services for future Google users, primarily in emerging markets. Before Google, Diana held senior positions at Standard Chartered Bank, including CEO, Africa Region; COO Wholesale Banking; and Group Head of Strategy & Corporate Development. Before joining Standard Chartered in 2004, she was CEO of a start-up technology company. Diana was previously a consultant at McKinsey & Co, becoming a sector lead for Healthcare and Life Sciences and advising pharmaceutical, biotech and other life sciences companies.
Diana has been a Non-Executive Director of Aggreko plc since 2012 and sits on the Board’s Audit, Ethics and Corporate Responsibility, and Nomination Committees. She is a Council Member of the London School of Hygiene & Tropical Medicine.
Diana has a BA degree from the University of Oxford and an MA in Public Administration and International Economics from Harvard University.
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information: https://www.astrazeneca.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.